KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Gains from Investment Securities (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Gains from Investment Securities data on record, last reported at $60000.0 in Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to $60000.0; the TTM value through Dec 2025 reached $7.2 million, changed N/A, while the annual FY2025 figure was $7.2 million, N/A changed from the prior year.
  • Gains from Investment Securities reached $60000.0 in Q4 2025 per IDXX's latest filing, down from $85000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $10.3 million in Q1 2022 and bottomed at $52000.0 in Q2 2022.
  • Average Gains from Investment Securities over 5 years is $2.2 million, with a median of $218000.0 recorded in 2024.
  • Peak YoY movement for Gains from Investment Securities: crashed 99.47% in 2021, then soared 1127.85% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $61000.0 in 2021, then dropped by 14.75% to $52000.0 in 2022, then skyrocketed by 30.77% to $68000.0 in 2023, then soared by 220.59% to $218000.0 in 2024, then tumbled by 72.48% to $60000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $60000.0 in Q4 2025, $85000.0 in Q3 2025, and $970000.0 in Q2 2025.